Visicell to present at the Next Generation CAR & T-Cell Therapies Conference

As part of Visicell's continuing efforts to help raise awareness among KOLs on the clinical benefits of non-invasive, actionable insights from cell therapy imaging, Visicell CEO, Mya Thu, in collaboration with Dr. Gilbert Fruhwirth of King's College London will be presenting at the Next Generation CAR & T-cell Therapies Conference on June 22, 2021 from 10:30am-10:50 PST in a presentation titled "Creating a Feedback Loop Between Clinical Trials and Translational Science for Product Improvement" on behalf of The HESI Cell Therapy - TRAcking, Circulation, & Safety (CT-TRACS) Committee.

If you missed the event, you can watch the recorded presentation here.

-Visicell Medical Team